Characterization of Neoantigen Load Subgroups in Gynecologic and Breast Cancers
ObjectiveAlthough gynecologic and breast (Pan-Gyn) cancers share a variety of similar characteristics, their response to immunotherapy is different. Immune checkpoint inhibitor therapy is not effective in all patients, while neoantigen load (NAL) may be a predictive biomarker. However, the selection...
Päätekijät: | , , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Frontiers Media S.A.
2020-07-01
|
Sarja: | Frontiers in Bioengineering and Biotechnology |
Aiheet: | |
Linkit: | https://www.frontiersin.org/article/10.3389/fbioe.2020.00702/full |